Shukra Pharmaceuticals Ltd — Important, 08-04-2026: Company Update

The company has filed a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations. This certificate confirms that all physical share certificates received for dematerialization were processed, mutilated, and cancelled within 15 days, and electronic credits were issued. This ensures the integrity of the company's share registry and proper handling of investor securities, reinforcing compliance with regulatory standards for demat accounts.